Takeda Pharmaceutical Company Limited (TAK)

NYSE: TAK · Pharmaceutical Preparations · Tokyo, JP · filing with the SEC since 2007

Grade5.7

◀ Past 7.8● Present 4.9▶ Future 4.4

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In millions of Japanese yen (JPY), as filed; per-share figures in Japanese yen; share counts in thousands.

The Form 20-F filed Jun 17, 2026 for the period ended Mar 31, 2026 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.

Income statement, by fiscal year, newest first
Fiscal year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Report filed	Jun 17, 2026	Jun 25, 2025	Jun 26, 2024	Jun 28, 2023	Jun 29, 2022	Jun 29, 2021	Jun 24, 2020	Jun 27, 2019	·	·
Revenue	4,505,720	4,581,551	4,263,762	4,027,478	3,569,006	3,197,812	3,291,188	2,097,224	1,770,531	1,732,051
Cost of revenue	1,571,588	1,580,217	1,426,678	1,244,072	1,106,846	994,308	1,089,764	651,729^r	495,921	558,755
Research and development	675,924	730,227	729,924	633,325	526,087	455,833	492,381	368,298	325,441	312,303
General and administrative	1,084,215	1,104,766	1,053,819	997,309	886,361	875,663	964,737	717,599	628,106	619,061
Operating income	6,217	342,586	214,075	490,505	460,844	509,269	100,408	237,685^r	241,789	155,867
Finance costs	357,572	210,065	219,850	169,698	166,607	248,631	165,006	83,289	31,928	23,249
Finance income	211,177	46,549	52,093	62,913	23,700	105,521	27,831	16,843	39,543	12,274
Share of profit of equity-method investments	-2,177	-3,986	6,473	-8,630	-15,367	76	-23,987	-43,627	-32,199	-1,546
Income before income taxes	-142,355	175,084	52,791	375,090	302,571	366,235	-60,754	127,612^r	217,205	143,346
Income tax expense	9,770	66,941	-91,406	58,052	72,405	-9,936	-105,044	-7,468^r	30,497	27,833
Net income	-152,125	108,143	144,197	317,038	230,166	376,171	44,290	135,080^r	186,708	115,513
Net income to non-controlling interests	264	215	130	21	107	166	49	-112	-178	573
Net income to shareholders	-152,390	107,928	144,067	317,017	230,059	376,005	44,241	135,192^r	186,886	114,940
Net income to ordinary shareholders	·	107,928	144,067	317,017	230,059	376,005	44,241	135,192^r	186,886	114,940
Earnings per share, basic	-96.75	68.36	92.09	204.29	147.14	240.72	28.41	140.61^r	239.35	147.15
Earnings per share, diluted	-96.75	67.23	91.16	201.94	145.87	238.96	28.25	139.82^r	237.56	146.26
Weighted average shares, basic	·	1,578,873	1,564,450	1,551,809	1,563,501	1,562,006	1,557,204	961,477	780,812	781,096
Weighted average shares, diluted	·	1,605,323	1,580,343	1,569,872	1,577,169	1,573,537	1,566,204	966,897	786,707	785,888

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:Revenue

Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfifrs-full:AdministrativeExpense

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Finance costs what its borrowing costifrs-full:FinanceCosts

Finance income what its cash and investments earnedifrs-full:FinanceIncome

Share of profit of equity-method investments its share of companies it partly ownsifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests

Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent

Net income to ordinary shareholders what is left for common shareholdersifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton TAK · research, not advice